Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation

Stéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, Anne-Claire Mamez, Stavroula Masouridi-Levrat, Dominik Heim, Jörg Halter, Gayathri Nair, Yves Chalandon, Urs Schanz, Tayfun Güngör, Grazia Nicoloso, Jakob R. Passweg, Jean Villard, on behalf of the Swiss Blood Stem Cell Transplantation Group

Blood Adv (2021) 5 (17): 3377–3386.

https://doi.org/10.1182/bloodadvances.2020003998

Published: 2021

Includes: Supplemental data

Journal Articles

Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia

Blood Adv (2021) 5 (17): 3279–3289.

https://doi.org/10.1182/bloodadvances.2021004631

Published: 2021

Includes: Supplemental data

Journal Articles

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Najla El Jurdi, Ahmad Rayes, Margaret L. MacMillan, Shernan G. Holtan, Todd E. DeFor, Judith Witte, Mukta Arora, Jo-Anne Young, Daniel J. Weisdorf

Blood Adv (2021) 5 (5): 1352–1359.

https://doi.org/10.1182/bloodadvances.2020003937

Published: 2021

Includes: Supplemental data

Journal Articles

Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma

Catherine S. Diefenbach, Brandilyn A. Peters, Huilin Li, Bruce Raphael, Tibor Moskovits, Kenneth Hymes, Jonas Schluter, J. Chen, N. Nora Bennani, Thomas E. Witzig, Jiyoung Ahn

Blood Adv (2021) 5 (5): 1194–1198.

https://doi.org/10.1182/bloodadvances.2020003129

Published: 2021

Includes: Supplemental data

Journal Articles

Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa

Nmazuo W. Ozuah, Joseph Lubega, Carl E. Allen, Nader Kim El-Mallawany

Blood Adv (2020) 4 (16): 4007–4019.

https://doi.org/10.1182/bloodadvances.2020002178

Published: 2020

Journal Articles

Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

Blood Adv (2020) 4 (15): 3509–3519.

https://doi.org/10.1182/bloodadvances.2020002218

Published: 2020

Includes: Supplemental data

Journal Articles

Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study

Filippo Milano, Jonathan A. Gutman, H. Joachim Deeg, Eneida R. Nemecek, Joachim Baumgart, Laurel Thur, Ann Dahlberg, Rachel B. Salit, Corinne Summers, Frederick R. Appelbaum, Colleen Delaney

Blood Adv (2020) 4 (14): 3302–3310.

https://doi.org/10.1182/bloodadvances.2020002222

Published: 2020

Includes: Supplemental data

Journal Articles

Hurdles in treating Hurler disease: potential routes to achieve a “real” cure

Brigitte T. A. van den Broek, Jaap van Doorn, Charlotte V. Hegeman, Stefan Nierkens, Caroline A. Lindemans, Nanda Verhoeven-Duif, Jaap Jan Boelens, Peter M. van Hasselt

Blood Adv (2020) 4 (12): 2837–2849.

https://doi.org/10.1182/bloodadvances.2020001708

Published: 2020

Journal Articles

High metabolic heterogeneity on baseline 18 FDG-PET/CT scan as a poor prognostic factor for newly diagnosed diffuse large B-cell lymphoma

Hajime Senjo, Kenji Hirata, Koh Izumiyama, Koichiro Minauchi, Eriko Tsukamoto, Kazuo Itoh, Minoru Kanaya, Akio Mori, Shuichi Ota, Daigo Hashimoto, Takanori Teshima, North Japan Hematology Study Group

Blood Adv (2020) 4 (10): 2286–2296.

https://doi.org/10.1182/bloodadvances.2020001816

Published: 2020

Includes: Supplemental data

Journal Articles

Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States

Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Rory M. Shallis, Nikolai A. Podoltsev, Jan P. Bewersdorf, Scott F. Huntington, Natalia Neparidze, Smith Giri, Steven D. Gore, Amy J. Davidoff, Xiaomei Ma

Blood Adv (2020) 4 (10): 2192–2201.

https://doi.org/10.1182/bloodadvances.2020001779

Published: 2020

Includes: Supplemental data

Journal Articles

Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match

Jayeeta Giri, Jacques Galipeau

Blood Adv (2020) 4 (9): 1987–1997.

https://doi.org/10.1182/bloodadvances.2020001711

Published: 2020

Includes: Supplemental data

Journal Articles

Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States

Amer M. Zeidan, Nikolai A. Podoltsev, Xiaoyi Wang, Chi Zhang, Jan Philipp Bewersdorf, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Smith Giri, Steven D. Gore, Amy J. Davidoff, Xiaomei Ma, Rong Wang

Blood Adv (2020) 4 (8): 1615–1623.

https://doi.org/10.1182/bloodadvances.2020001728

Published: 2020

Journal Articles

Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL

Blood Adv (2020) 4 (6): 1038–1050.

https://doi.org/10.1182/bloodadvances.2019001396

Published: 2020

Includes: Supplemental data

Journal Articles

CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation

Boris A. Bartholdy, Xiahoua Wang, Xiao-Jie Yan, Marién Pascual, Manxia Fan, Jacqueline Barrientos, Steven L. Allen, Jose Angel Martinez-Climent, Kanti R. Rai, Nicholas Chiorazzi, Matthew D. Scharff, Sergio Roa

Blood Adv (2020) 4 (5): 893–905.

https://doi.org/10.1182/bloodadvances.2019000817

Published: 2020

Includes: Supplemental data

Journal Articles

Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia

Richard C. Harvey, Sarah K. Tasian

Blood Adv (2020) 4 (1): 218–228.

https://doi.org/10.1182/bloodadvances.2019000163

Published: 2020

Journal Articles

Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT

Talha Badar, Narendranath Epperla, Aniko Szabo, Steven Borson, John Vaughn, Gemlyn George, Neeraj Saini, Abdul Rashid Shah, Romil D. Patel, Sairah Ahmed, Nirav N. Shah, Amanda F. Cashen, Mehdi Hamadani, Timothy S. Fenske

Blood Adv (2020) 4 (1): 47–54.

https://doi.org/10.1182/bloodadvances.2019000736

Published: 2020

Journal Articles

Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes

Blood Adv (2019) 3 (24): 4228–4237.

https://doi.org/10.1182/bloodadvances.2019000925

Published: 2019

Includes: Supplemental data

Journal Articles

Impact of γδ T cells on clinical outcome of hematopoietic stem cell transplantation: systematic review and meta-analysis

Lucas C. M. Arruda, Ahmed Gaballa, Michael Uhlin

Blood Adv (2019) 3 (21): 3436–3448.

https://doi.org/10.1182/bloodadvances.2019000682

Published: 2019

Includes: Supplemental data

Journal Articles

Association between clinical outcomes and metformin use in adults with sickle cell disease and diabetes mellitus

Sherif M. Badawy, Amanda B. Payne

Blood Adv (2019) 3 (21): 3297–3306.

https://doi.org/10.1182/bloodadvances.2019000838

Published: 2019

Includes: Supplemental data

Journal Articles

DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes

Brian Reilly, Tiffany N. Tanaka, Dinh Diep, Huwate Yeerna, Pablo Tamayo, Kun Zhang, Rafael Bejar

Blood Adv (2019) 3 (19): 2845–2858.

https://doi.org/10.1182/bloodadvances.2019000192

Published: 2019

Includes: Supplemental data

NARROW

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation

Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma

Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa

Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study

Hurdles in treating Hurler disease: potential routes to achieve a “real” cure

High metabolic heterogeneity on baseline 18 FDG-PET/CT scan as a poor prognostic factor for newly diagnosed diffuse large B-cell lymphoma

Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States

Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match

Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States

Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL

CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation

Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia

Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT

Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes

Impact of γδ T cells on clinical outcome of hematopoietic stem cell transplantation: systematic review and meta-analysis

Association between clinical outcomes and metformin use in adults with sickle cell disease and diabetes mellitus

DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only